January 2026 Introduces Medicare Drug Price Negotiations, Setting a New Direction for Prescription Costs and Long-Term Healthcare Policy
January 1, 2026 marks a turning point in U.S. healthcare policy that has been debated for decades but never executed in practice. For the first time, Medicare will begin enforcing negotiated prices on select prescription drugs, moving beyond indirect cost controls into direct price intervention. This change is not symbolic. It represents the first […]









